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Osteoblasts expressing the homophilic adhesion
molecule N-cadherin form a hematopoietic stem cell
(HSC) niche. Therefore, we examined howN-cadherin
expression inHSCs relates to their function.We found
that bonemarrow (BM) cells highly expressingN-cad-
herin (N-cadherinhi) are not stem cells, being largely
devoid of a LineageSca1+cKit+ population and
unable to reconstitute hematopoietic lineages in irra-
diated recipient mice. Instead, long-term HSCs form
distinct populations expressing N-cadherin at inter-
mediate (N-cadherinint) or low (N-cadherinlo) levels.
The minority N-cadherinlo population can robustly
reconstitute the hematopoietic system, express
genes that may prime them to mobilize, and predom-
inate among HSCs mobilized from BM to spleen. The
larger N-cadherinint population performs poorly in
reconstitution assays when freshly isolated but
improves in response to overnight in vitro culture.
Their expression profile and lower cell-cycle entry
rate suggest N-cadherinint cells are being held in
reserve. Thus, differential N-cadherin expression
reflects functional distinctionsbetween twoHSCsub-
populations.
INTRODUCTION
It is well accepted that stem cell niches play critical roles in the
regulation of hematopoietic stem cell (HSC) behavior (Schofield,
1978). In BM, HSCs reside in ‘‘osteoblastic’’ (Arai et al., 2004;
Calvi et al., 2003; Zhang et al., 2003) and ‘‘vascular’’ niches
(Kiel et al., 2005), which may have complementary functions
(Kopp et al., 2005; Yin and Li, 2006).
In the osteoblastic niche, HSCs associate with a subset of
osteoblasts lining the endosteal surface that express N-cadherin
(Cdh2, a calcium-dependent adhesion molecule) (Arai et al.,
2004; Zhang et al., 2003). Accumulated evidence suggests thatcadherins are not only required for stem cell anchoring to the
niche (Song and Xie, 2002) but also influence the cycling state
of HSCs (Wilson et al., 2004). The cycling state of HSCs is linked
to their potential, as measured by reconstitution assay. Notably,
quiescent subpopulations of HSCs are enriched with long-term
(LT) HSCs capable of sustaining hematopoiesis for many
months, whereas cycling HSC subpopulations are enriched
with short-term (ST) HSCs unable to sustain reconstitution be-
yond a few weeks (Fleming et al., 1993).
It is believed the most primitive quiescent HSCs anchored in
the niches have the most efficient reconstitution (Arai et al.,
2004), but it is not yet known whether there is any direct relation-
ship between expression of niche-interaction molecules such
as N-cadherin and the properties of HSCs. We hypothesized
that N-cadherin, present at the interface between HSCs and
the osteoblastic niche in both mice and humans (Arai et al.,
2004; Muguruma et al., 2006; Zhang et al., 2003), would identify
quiescent HSCs and thus expected BM cells or HSCs express-
ing high levels of N-cadherin to have robust reconstitution
activity. We found, however, that BM cells with the highest levels
of N-cadherin expression were not HSCs. Instead, expression of
N-cadherin at intermediate (N-cadherinint) or low (N-cadherinlo)
levels divided HSCs into two populations with numerous molec-
ular and functional distinctions. Our data suggest N-cadherinlo
HSCs fulfill ongoing hematopoiesis, whereas N-cadherinint
HSCs are held in reserve to support LT maintenance of the
hematopoietic system.
RESULTS
LT-HSCs Predominantly Express Low-to-Intermediate
Levels of N-Cadherin
N-cadherin may mediate niche interaction, so we tested whether
N-cadherin+ HSCs could reconstitute the hematopoietic system.
Using a polyclonal anti-N-cadherin antibody, we previously
found that 10% of LinSca1+cKit+ (LSK) stem and progenitor
cells express N-cadherin (Zhang et al., 2003). In this study, we
instead used a rat-anti-mouse N-cadherin monoclonal antibody
(mAb) that exhibited superior specificity for mouse N-cadherin
(see Figure S1 available online). In fluorescence-activated cellCell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 367
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N-Cadherin Level Distinguishes HSC StateFigure 1. Examination of N-Cadherin Expression in Bone Marrow and HSCs
(A) Analysis of N-cadherin+ cells in BM using flow cytometry. Colored outlines indicate N-cadherin positive (red) and low/negative (blue) BM populations selected
for transplant.
(B) Levels of N-cadherin in Lin cells assessed by flow cytometry. Lineage-negative (Lin) cells were further separated into subpopulations according to N-cad-
herin expression: negative, low, intermediate, and high (red boxes). The upper threshold of FMO controls provides the lower limit of signal in the N-cadherinint
population. The term N-cadherinlo applies to the population just below this boundary because these cells are mRNA-positive and brighter on the N-cadherin axis
in FACS than the dimmest, mRNA-negative ones.
(C and D) Real-time RT-PCR detection of N-cadherin mRNA. Shown are representative products (C) and a relative expression obtained from triplicate reactions
(D). BM was used as positive control. Error bar is 1 SD.
(E) N-cadherin RT-PCR strategy and specificity. RT-PCR primers span exon2/3 junction interrupted by 124 kb intron in genomic DNA. Product sequenced with
RT-PCR primers has >99% identity with N-cadherin reference sequence (NM_007664).
(F–I) LSK content of Lin populations with varying N-cadherin levels.368 Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc.
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senting 0.78% ± 0.6% (n = 12) of the total BM (Figure 1A). Trans-
planting 5000 cells, we found that N-cadherin-expressing BM
failed to reconstitute hematopoietic lineages in recipient mice,
yet BM with only limited N-cadherin expression reconstituted
in one of five cases (Table S1). Surprised by this result, we ex-
plored N-cadherin expression further, separating BM into mature
(lineage-positive, Lin+) hematopoietic cells (Christensen and
Weissman, 2001) and a Lin population known to be enriched
with stem and progenitor cells. In multiparameter FACS, it can
be challenging to distinguish dim fluorescent cells from the truly
negative. To address this, we employed fluorescence minus one
(FMO) staining controls, combinatorial panels that omit each
fluorescent reagent or replace it with an isotype control
(Roederer, 2001), and we combined FACS with RT-PCR. Within
the Lin cell population, four different subpopulations were ob-
served based on the expression level of N-cadherin: negative
(N-cadherin), N-cadherinlo, N-cadherinint, and N-cadherinhi
(Figure 1B). The N-cadherinhi population was predominantly
Lin+ (Figure 1B), explaining its failure to reconstitute. Real-time
RT-PCR confirmed N-cadherin mRNA was present in LinN-
cadherin+ cells, including LinN-cadherinlo and LinN-cadheri-
nint cells, but not in the LinN-cadherin cells (Figures 1C and
1D). Amplicon specificity was confirmed by DNA sequence anal-
ysis (Figure 1E). These four subpopulations of Lin cells
exhibited distinct Sca-1/cKit expression profiles (Figures 1F–
1I), with N-cadherinint cells being most enriched with LSK stem
and progenitors (23%). For these and all subsequent figures,
red italic type indicates gating strategies of the displayed cells,
and horizontal and vertical region markers are set using FMO
controls.
Next, we analyzed the LSK cells by using N-cadherin and Flk2,
which has been shown to separate LT (Flk2) and ST (Flk2+)
HSCs (Christensen and Weissman, 2001) (Figures 1J and 1K).
We found the LSKs were mainly composed of N-cadherinlo
and N-cadherinint cells. LT-HSCs (Flk2LSKs) were almost
exclusively N-cadherinint or N-cadherinlo; N-cadherin cells
were mainly Flk2+, while N-cadherinhi cells were rarely detected
(Figures 1K and 1L). Real-time RT-PCR confirmed the expres-
sion of N-cadherin mRNA in both N-cadherinlo and N-cadheri-
nintFlk2LSK cells compared to LinN-cadherin cells
(Figure 1M; Figure S2). Since our focus was LT-HSCs, FACS
gating hereafter was designed to separate N-cadherinint from
N-cadherinlo.
To locate N-cadherin+ HSCs on BM sections, we used
a mouse line (N-cadherin-LacZ) with a LacZ reporter gene trap-
ped in at the N-cadherin locus (Luo et al., 2005) and CD201,
a marker shown to explicitly identify HSCs (Balazs et al., 2006)
(Supplemental Experimental Procedures). The majority of the
BM cells were LacZ negative. Morphologically, the N-cadherin-
LacZhi BM cells appeared to be mature cells with irregular nuclei
and a high cytoplasm to nucleus ratio (red arrows in Figures S3A
and S3B). This further explained why N-cadherinhi BM lacked re-
constitution activity. Consistent with previous findings that HSCsattach to spindle-shaped N-cadherin+ osteoblasts (Zhang et al.,
2003), we detected moderate N-cadherin-LacZ expression in
CD201+ cells adjacent to osteoblasts that were strongly positive
for LacZ (Figures S3C–S3E).
N-CadherinloFlk2LSK Cells Robustly Repopulate
Hematopoietic Lineages in Recipient Mice
We performed competitive repopulation assays to determine if
N-cadherin+LSK cells contain functional HSCs. Consistent with
a previous report (Christensen and Weissman, 2001), the
Flk2+LSK cells rarely reconstituted the hematopoietic lineages
long-term (data not shown). We transplanted 25 N-cadherinlo or
25 N-cadherinint Flk2LSK cells (CD45.2+) into lethally irradiated
recipient mice (CD45.1+). N-cadherinlo donor cells gave higher
engraftment of multiple hematopoietic lineages (four of five mice
exhibited engraftment; average 53%) than N-cadherinint (two of
five engrafting; average 1.4%), a result typical of several replicate
experiments (Figure 2A, Table S1). As Slamf1+ (CD150) HSCs are
reported to be enriched with LT-HSCs (Kiel et al., 2005), we also
assayed CD150+ Flk2LSKs. CD150+ LSKs were enriched in
Flk2LSK and represented 12.5%–25% of the Flk2LSK popula-
tion (Figure 2B). Average engraftment of CD150+Flk2LSKs
(3.2%) was low compared to N-cadherinloFlk2LSKs (53%) but
better than N-cadherinintFlk2LSKs (1.4%) (Figure 2C) and con-
trasts with the strongly reconstituting SLAM code HSCs previ-
ously isolated as CD150+ CD48CD41 (Kiel et al., 2005). This
difference likely stems from use of the negative markers CD48
and CD41. Specifically, CD150+CD48CD41 cells (Figure 2D)
were predominately (67.5%) N-cadherinloFlk2 cells (Figure 2E),
whereas just 14% of CD150+Flk2LSK were N-cadherinlo
(Figure 2F).
Overnight In Vitro Culture Improves the Reconstitution
Activity of N-CadherinintFlk2LSK
We next asked whether N-cadherinint and N-cadherinlo
Flk2LSK retained their distinct N-cadherin expression and
reconstitution ability upon overnight culture in serum-free STIF
media (Zhang et al., 2006). N-cadherin expression levels prior
to culture were compared to those observed in the same cells re-
stained with the mAb postculture. To control for differences in
HSC staining/handling, we restained cells held at 4C in STIF
but not cultured. Culturing the N-cadherinlo population gener-
ated a sizable population of non-LSK cells (Figures 2G–2I). In
contrast, culturing shifted a majority of N-cadherinint cells to N-
cadherinlo (Figures 2J and 2L) while retaining a large portion of
the cells as LSK (Figure 2K). N-cadherinint cells held at 4C re-
sembled the input population. To assess the functional impact
of culture, we transplanted 25 or 100 freshly isolated cells or
overnight cultured cells derived from the same number of input
cells (we used 100 N-cadherinint Flk2LSKs, since 25 fresh cells
had given minimal reconstitution). The culture step increased the
engraftment rate of 100 N-cadherinint Flk2LSK to an average of
14.2% (Figure 2M), whereas it reduced the average engraftment
of 25 N-cadherinlo Flk2LSKs (compare Figures 2C and 2M).(J–M) Analyses of LSK cells with Flk2 and N-cadherin markers using flow cytometry. (J) Isolation of LSK population. (K) Subdivision of LSK by Flk2 and N-cad-
herin. Divisions of N-cadherin expression (neg, lo, int, and hi) applied signal thresholds in the same relative positions as those used for the Lin population (B). (L)
Proportions of N-cadherin, N-cadherinlo, and N-cadherinint and N-cadherinhi in Flk2+ and Flk2LSK cells. (M) Determination of N-cadherin mRNA levels in
LT-HSCs using real-time RT-PCR. Error bar is 1 SD; number of cells, 400.Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 369
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herinlo and N-Cadherinint Flk2LSK Cells
with CD150+Flk2LSK Cells
(A) Reconstitution activity of 25 N-cadherinlo (blue)
and N-cadherinint (orange) Flk2LSK cells. At 1, 2,
and 3 months, engraftment was measured by flow
cytometry analysis of donor (CD45.2) cells present
in recipient PB. Values indicate average engraft-
ment at 3 months.
(B) Analysis of CD150 expression in Flk2LSKs.
Representative histogram shows CD150 signal
(blue) and FMO isotype control (red). Bar indicates
CD150+ population.
(C) Comparison of the reconstitution activity of
25 CD150+, N-cadherinlo, and N-cadherinint
Flk2LSKs. Graph shows the individual (A) and
average (—) percentage of PB CD45.2 cells pres-
ent in engrafted recipients at 3 months posttrans-
plant.
(D) Representative analysis of BM using the
standard SLAM code method. Proportion of
CD150+CD48CD41 cells shown is average of
five experiments.
(E) Analysis of BM SLAM code cells, gated as in
(D), for N-cadherin and Flk2.
(F) N-cadherin and CD150 expression in
Flk2LSKs.
(G–L) Impact of overnight incubation in STIF me-
dium on N-cadherinlo Flk2LSKs (N-cadlo) (G–I)
and N-cadherinint Flk2LSKs (N-cadint) (J–L). (G
and J) Comparison of N-cadherin expression be-
fore (green) and after (red) 16 hr culture in STIF me-
dium at 37C, as well as cells held at 4C (blue). (H
and K) Assessment of LSK content after overnight
culture. Proportion of LSKs is indicated above the
gate. (I and L) N-cadherin and Flk2 expression in
LSKs isolated from overnight cultures of cultured
N-cadlo and N-cadint cells.
(M) Reconstitution activity of 100 STIF cultured N-
cadherinint Flk2LSKs (#1), 25 STIF cultured N-
cadherinlo Flk2LSKs (#2), and 100 freshly isolated
N-cadherinint Flk2-LSK cells (#3) in primary trans-
plant recipients analyzed at 4 months. Percent-
ages of donor (CD45.2) cells in PB are shown for
individual engrafted recipients (A) and as aver-
ages (—).
(N) Following culture, N-cadherinint and N-cadher-
inlo Flk2-LSKs give multilineage engraftment 4
months after primary transplant. BM of the en-
grafted recipients was analyzed for donor-derived
(CD45.2) B220 (B cells, ‘‘B’’), CD3 (T cells, ‘‘T’’), and
mac1+/Gr1+ (myeloid cells, ‘‘M’’). Error bar is 1 SD.
(O) N-cadherin and Flk2 expression in donor-de-
rived BM LSKs 6 months following primary trans-
plantation of cultured N-cadherinint Flk2-LSKs.
(P) Reconstitution activity of 100 donor-derived
BM LSKs from primary recipients of cultured N-
cadherinlo (blue) and cultured N-cadherinint (or-
ange) Flk2LSK cells. Donor (CD45.2) contribution
to secondary recipient PB was assessed at 1, 2,
and 3 months. All engrafted recipients (2 of 7 for
N-cadherinint; 4 of 10 for N-cadherinlo) are shown.Cultured N-cadherinint Flk2LSKs provided effective reconsti-
tution of all lineages examined (T, B, and myeloid) (Figure 2N).
They also gave rise to LSKs whose profile of Flk2 and N-cadherin
expression resembled that of normal nontransplanted mice370 Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc.(compare Figures 2O and 1K). Six months after the initial trans-
plant, we performed secondary transplants from well-engrafted
primary recipients. We found that, whether originating from
cultured N-cadherinint or cultured N-cadherinlo Flk2LSKs, 100
Cell Stem Cell
N-Cadherin Level Distinguishes HSC StateFigure 3. Gene Expression Profiles Distinguish N-Cadherinint and N-Cadherinlo Flk2LSKs
(A) Separation of LSKs into four populations for microarray analysis according to N-cadherin (N) and Flk2 (F) expression (F+Nlo, F+Nint, FNlo, FNint). Gating strat-
egy (center) is flanked by representative postsorts showing the purity of the four populations after the first of two serial FACS sorts.
(B) Heat map representation of variation across the four populations (red, high expression; blue, low expression) of the 272 most differential array probes clus-
tered by similar expression profiles.
(C and D) Principal component (PC) analysis performed on raw array intensities for all samples (C) or on background-corrected, normalized population means (D).
Plots show average expression data in the plane defined by the first two PCs of the data set (PC#1, PC#2). Proportions of total data variance attributed to each PC
are indicated in parentheses. Ellipses in (C), standard errors for the population means, have minimal or no overlap when an axis effectively separates the pop-
ulations.
(E) Heat maps illustrating the expression profiles of genes both differentially expressed between FNint and FNlo (>1.75-fold) and with highest or lowest expres-
sion occurring in population FNint (left) or FNlo (right).donor-derived LSKs provided effective reconstitution for sec-
ondary recipients 3 months after transplantation (Figure 2P)
and contributed to T, B, and myeloid lineages (data not shown).
Thus, N-cadherinintFlk2LSKs do have the capacity to provide
LT multilineage reconstitution if transplanted postculture rather
than as freshly isolated cells.
N-Cadherin Level Separates Flk2LSKs intoMolecularly
Distinct Populations
To build gene-expression profiles of stem and progenitor cells
with different N-cadherin levels, we sorted LSKs into four popu-
lations according to surface Flk2 and N-cadherin expression(Figure 3A), resorted to increase purity, and performed triplicate
microarray studies. Sorting directly into Trizol for RNA prepara-
tion precluded determination of final purities, but the first FACS
step gave purities around 80%, and equivalent double-sorted
populations were around 95% pure. Most genes varied little
among these populations. Analysis of probes with the most
differential signals (see the Supplemental Experimental Proce-
dures) revealed that the Flk2+ populations (F+Nlo and F+Nint)
commonly gave similar signal levels but were distinct from the
two Flk2 populations (FNlo and FNint), which in turn frequently
differed from each other (Figure 3B). Thus, N-cadherin levels
separated Flk2 LT-HSCs into distinct populations but hadCell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 371
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N-Cadherin Level Distinguishes HSC Statelimited impact on the expression profile of Flk2+ ST-HSCs and
progenitors. Principal component analysis (PCA) (Figure 3C),
which identifies and orders sources of variation within large
data sets (Raychaudhuri et al., 2000) (see the Supplemental
Experimental Procedures), demonstrated that Flk2 status was
the most significant determinant of variation among the four pop-
ulations. Whether PCA was performed on all samples (Figure 3C)
or on population means (Figure 3D), the first principal component
(PC1, responsible for the greatest variation in the data set) sep-
arated populations F+Nlo and F+Nint from populations FNlo and
FNint. Moreover, Flk2 mRNA expression was very strongly cor-
related (Pearson correlation coefficient r = 0.97931) with the
population mean PC1 axis.
PC2, the next largest source of variation in the data set, sepa-
rated populations FNlo and FNint, but not F+Nlo and F+Nint.
FNlo and FNint were defined on the basis of surface N-cadherin
protein, yet N-cadherin mRNA levels only weakly correlated with
the population mean PC2 (r = 0.60), perhaps implying addi-
tional posttranscriptional control. Real-time RT-PCR similarly
showed that N-cadherinlo and N-cadherinint populations differ
only modestly in N-cadherin mRNA levels. Gene ontology analy-
sis for genes highly correlated with PC2 (jrj > 0.95) indicated that
the cell populations separated by this axis likely differed in met-
abolic status, signaling, and cell-cycle control (Table S2). Genes
positively correlated with PC2 (more highly expressed in FNlo
than in FNint) were involved in protein biosynthesis and nucleo-
tide metabolism, suggesting that N-cadherinlo HSCs may be
more active than their N-cadherinint counterparts. Conversely,
the negatively correlated gene set (expressed more highly in
FNint) was overrepresented in genes encoding insulin signaling
pathway components, regulators of signal transduction, and
cell-cycle proteins.
N-Cadherinint and N-Cadherinlo Stem Cells Differ
in Expression of Key HSC Regulators
To help identify the basis of their distinct reconstitution abilities,
we identified genes with a >1.75-fold difference in expression
between populations FNint and FNlo, focusing on those in
which FNint or FNlo expression was the highest or lowest of
the four populations examined (see the Supplemental Experi-
mental Procedures). This generated 48 genes in four sets (FNint
lowest, FNint highest, FNlo lowest, and FNlo highest) (Fig-
ure 3E; Table S3).
Genes with highest expression in FNlo, the population with
the greatest reconstitution ability, included chemokine (C-C
motif) receptor 2 (Ccr2), chemokine (C-C motif) ligand 5 (Ccl5),
and neurotrophin 5(Ntf5), all of which are involved in locomotor
activity or chemotaxis (Moser et al., 2004; Tucker et al., 2001).
In contrast to the high Ccr2 mRNA expression observed in FNlo,
we found that the poorly reconstituting FNint population
showed particularly low levels of colony-stimulating factor 1 re-
ceptor (Csf1r) and insulin-like growth factor 2 receptor (Igf2r)
mRNAs, suggesting differential responsiveness to signaling mol-
ecules. Igf2r may be regulated by different mechanisms in FNlo
and FNint, since FNlo had high levels of Air, the Igf2r antisense
transcript (Sleutels et al., 2002). Scl22a3, a gene in the FNint
highest group, is also regulated by Air.
Differential adhesion/matrix interaction between the two cell
populations was suggested in that population FNint expressed372 Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc.high levels of tissue inhibitor of metalloproteinase 2 (Timp2), as
well as the adhesion molecule integrin alpha 2b (Itga2b) and de-
velopment and differentiation enhancing factor 2 (Ddef2), which
acts in integrin signaling. However, this population also had the
lowest mRNA level of CEA-related cell adhesion molecule 1.
Differentially expressed genes known to act in hematopoietic
cell lineage include Csf1r (lowest in FNint) and Itga2b (highest
in FNint). FNlo expressed the highest levels of nephroblastoma
overexpressed (Nov), a marker for the undifferentiated state nec-
essary for effective reconstitution by human HSCs in xenograft
assays (Gupta et al., 2007). Our four gene sets were relatively
enriched (4.08-fold, p = 0.0162) in the GO term ‘‘regulators of
cell proliferation.’’ B cell leukemia/lymphoma 11B (Bcl11b) and
the Wnt effector Tcf7 were both high in group FNlo, whereas
E2F transcription factor 7 (E2F7) was low in population FNlo
and Timp2 was high in population FNint.
Of our 48 differential genes, 13 have been reported to be dif-
ferentially expressed in hematopoietic stem and progenitor cells
(Akashi et al., 2003; Forsberg et al., 2005; Terskikh et al., 2003;
Tydell et al., 2007), confirming that they dynamically alter early
in the hematopoietic lineage. For all four genes expressed high-
est or lowest in FNint HSCs (Cnn3, Dach1, Timp2, and Csrl1),
the known profile is consistent with equivalence of these HSCs
and the previously studied LT-HSC/HSC population (i.e., if
lowest [or highest] in FNint HSCs, they are correspondingly
expressed at lower [or higher] levels in LT-HSCs/HSCs than in
various progenitors).
Just two of the nine genes highest or lowest in FNlo (Neo1 and
Socs2) fit reported expression profiles. Six with highest expres-
sion in FNlo (Bclllb, Car1, Lgals, Mpo, Prtn3, and Tcf7) are either
more highly expressed in ST-HSCs, multipotent progenitors
(MPPs) or pro-T cells than in LT-HSCs, or more highly expressed
in MPP, granulocyte-macrophage progenitors, or common mye-
loid progenitors than in HSCs. Likewise, Eya1 (lowest in FNlo) is
expressed at higher levels in HSCs than in a variety of progeni-
tors. Thus, FNlo, while functioning as LT-HSCs, may possess
certain molecular properties previously ascribed to ST-HSCs
or progenitors.
N-Cadherinint and N-Cadherinlo Stem Cells Enter
the Cell Cycle at Different Rates
To assess whether FNint and FNlo populations differed in cell-
cycle regulation, we performed prolonged labeling of cycling
cells with BrdU and examined label incorporation rates, a strat-
egy recently used to calculate the cell-cycle entry rate for
CD150+CD48CD41 HSCs at around 6% per day (Kiel et al.,
2007a). With 1, 4, or 8 days of labeling, the percentage of
BrdU+ cells was consistently higher in FNlo than in the FNint
population. After 8 days of labeling, 42% of FNlo cells, but
only 22% of FNint cells, were BrdU+ (Figures 4A and 4B). Cell-
cycle entry rates, calculated by regression on the log of the
proportion of unlabeled cells (Kiel et al., 2007a) (Figure 4C),
revealed that 6.7% of FNlo HSCs entered the cell cycle
each day, compared with only 3.2% per day for FNint HSCs.
N-Cadherin and CD150 Have Distinct Expression
Dynamics in HSCs
Most (67%) CD150+CD48CD41 HSCs are N-cadherinlo
(Figure 2E), so we examined how N-cadherin and CD150
Cell Stem Cell
N-Cadherin Level Distinguishes HSC Stateexpression related to different states of HSCs using a population
undergoing relatively synchronous activation and expansion
(increase in number). A single high-dose treatment with the che-
motherapeutic agent 5-fluorouracil (5FU) purges progenitors and
cycling HSCs and spares primitive HSCs (Lerner and Harrison,
1990; Venezia et al., 2004) (Figure 5A). On day 3 post-5FU treat-
Figure 4. Comparison of Cell-Cycle Entry
Rates in N-Cadherinlo and N-Cadherinint
Flk2LSKs
(A and B) BrdU incorporation in N-cadherinlo and
N-cadherinint Flk2LSKs after in vivo BrdU label-
ing for zero (negative control) 4 or 8 days. (A) Pho-
tomicrographs show representative BrdU immu-
nostaining performed on the sorted populations
indicated. Arrows indicate positive cells. (B) BrdU
incorporation data expressed as percentage
BrdU+ (number BrdU+/total cells counted). Posi-
tive and negative cells were counted in a blinded
study using three or four independent samples.
(C) Regression of log10 of percent nonlabeled cells
used to determine the average per day BrdU incor-
poration (cell-cycle entry) rate. BrdU+ cells may
have cycled one or multiple times, complicating
assessment of cell-cycle entry rate. However, if
p = the proportion of cells in S phase (incorporat-
ing label) each day, then the proportion of nonla-
beled cells after day d is (1  p)d. Thus, p can be
calculated from the slope of log (nonlabeled cells).
Regression lines assume that y = 2 at d = 0 (0%
labeling at day zero). The calculated values of p
are shown (as % per day). The fit of the data to
each regression line is given by the R2 value.
ment, the LSK population was drama-
tically reduced (from 0.25% to 0.003%)
(Figure 5B). By day 5 post-5FU, LSK num-
bers started to recover, indicative of HSC
expansion (Figures 5B and 5C). Quantita-
tive real-time RT-PCR on Flk2LSKs indi-
cated mRNA levels of cyclinD1, a factor
required for progression through G1,
steadily increased from day 1 through 5
post-5FU (Figure 5D). N-cadherin exhi-
bited a strong peak in mRNA expression
as the LSK number reached a minimum
but declined again at day 5 when expan-
sion was underway (Figure 5E). In con-
trast, CD150 mRNA was low at day 3
but upregulated again in the expansion
phase (Figure 5F).
To examine the coexpression pattern of
N-cadherin and CD150 in individual cells,
we performed single-cell RT-PCR for N-
cadherin, Bmi1, CD150, and HPRT on
Flk2LSKs on day 3 post-5FU. All cells
analyzed were HSCs, as they expressed
the self-renewal gene Bmi1 (Park et al.,
2003). We also noted a largely reciprocal
expression pattern between N-cadherin
and CD150 (Figure 5G) on day 3 post-
5FU. A low fraction of cells expressed both N-cadherin and
CD150.
With flow cytometry, we were able to assay much larger num-
bers of cells and examine protein level expression. Under ho-
meostatic conditions, the LSK population contained few
CD150+ cells, and surface expression of N-cadherin andCell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 373
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N-Cadherin Level Distinguishes HSC StateFigure 5. Examination of N-Cadherin and CD150 in HSCs Following 5FU Treatment
(A) 5FU provokes widespread changes in HSC behavior, eliminating cycling progenitors (purple) but sparing some quiescent HSCs (red). Surviving HSCs are
prompted to proliferate.
(B) HSC (Flk2LSK) numbers in BM following single-dose 5FU treatment.
(C) Deduced timeline of HSC destruction, activation, and expansion.
(D–F) Effect of 5FU treatment on the mRNA expression of CyclinD1 (D), N-cadherin (E), and CD150 (F) in HSCs, assessed by quantitative real-time RT-PCR
analysis of 400 Flk2LSK. Transcript level is normalized using expression of HPRT. Error bar is 1 SD.
(G) Multiplex gene expression analyses of N-cadherin, Bmi, and CD150 in single-sorted LSK cells 3 days post-5FU treatment using real-time RT-PCR with HPRT
as an internal control. The fraction of the cells exhibiting each profile shown is given in parentheses.
(H and I) Examination of the change in N-cadherin and CD150 expression at the protein level in HSCs spared by 5FU treatment (I) compared to normal LSK
cells (H).374 Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc.
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N-cadherinloCD150 subpopulation was depleted, and thus
relatively sensitive to 5FU treatment, whereas populations
with reciprocal patterns of N-cadherin and CD150 (N-cad-
herinloCD150+ and N-cadherinintCD150) were relatively resis-
tant and made up two-thirds of the LSKs (Figure 5I). Preferential
destruction of the more rapidly cycling Flk2+ cells (including
many N-cadherinlo and N-cadherinint cells, but few CD150+) ex-
plained some, but not all, of the alteration in the N-cadherin and
CD150 profile. Thus, there is differential survival of specific sub-
populations of HSCs and/or coordinate and reciprocal regulation
of N-cadherin and CD150 in HSCs following 5FU treatment.
Figure 6. Examination of N-Cadherin and CD150 Expression in
Mobilized HSCs
(A–F) Analysis of LSK and LT-HSCs under homeostatic conditions (A, C,
and E) and 14 days post-5FU treatment (B, D, and F). (A and B) Quantifi-
cation of LSKs (blue boxes) in normal spleen (A) and in spleen 14 days
post-5FU. (C–F) Expression of N-cadherin and Flk2 in LSKs (C and E) or
N-cadherin and CD150 in LT-HSCs (D and F) in normal BM and spleen
14 days post-5FU.
(G) Comparison of expression of N-cadherin in LSKs in BM and PB
10 days post-5FU treatment.
Mobilized HSCs Are Predominantly
N-Cadherinlo Cells
Association of N-cadherin and CD150 with osteoblastic and
vascular niches implies our two relatively 5FU-resistant LSK
populations (N-cadherinintCD150 and N-cadherinloCD150+)
could represent HSCs residing in osteoblastic and vascular
niches, respectively. Mobilized HSCs are predominantly
located in the vascular niche (Kiel et al., 2005), so we exam-
ined the N-cadherin and CD150 expression profiles of
HSCs mobilized to the spleen 14 days post-5FU treatment.
Normally, LSKs are rarely detected in the spleen (Fig-
ure 6A); however, 2 weeks after 5FU treatment, spleen LSK
number was dramatically increased, indicating mobilization
of HSCs from BM (Figure 6B). In BM, just 15%–20% of
Flk2LSKs were N-cadherinlo, but Flk2LSKs mobilized to
spleen were predominantly N-cadherinlo (87%) (Fig-
ure 6D). Spleen-mobilized HSCs were also commonly
CD150+ cells, as indicated by the substantial increase in
CD150+N-cadherinlo Flk2LSK cells (from 1.6% before to
39% after treatment) (compare Figures 6E and 6F). At earlier
time points, mobilizing LSKs were found in PB. Ten days post
5FU, the PB LSKs were almost exclusively N-cadherinlo,
whereas BM LSKs were largely N-cadherinint (Figure 6G).
We conclude that (1) the majority of HSCs mobilized to spleen
are N-cadherinlo, (2) this population is also enriched with
CD150+ cells, and (3) HSCs are N-cadherinlo during mobiliza-
tion and do not merely adopt this state upon arrival in a spleen
vascular niche.
DISCUSSION
Low and Intermediate Levels of N-Cadherin
Expression Distinguish Two HSC States
We had hoped that high N-cadherin levels might identify
quiescent HSCs capable of effective reconstitution but
found instead that N-cadherinhi cells were mainly mature and
thus incapable of reconstituting the hematopoietic system. A
recent parallel study likewise showed N-cadherinhi cells are not
HSCs (Kiel et al., 2007b). However, analyzing a commonly stud-
ied HSC population, mouse Flk2LSKs, we found that the vast
majority were confined to the N-cadherinint and N-cadherinlo
fractions and were rarely observed as negative for or highly
expressing N-cadherin.
Unexpectedly, within freshly isolated LT-HSCs, only the
minority N-cadherinloFlk2LSK population (FNlo) could effec-
tively reconstitute the hematopoietic system of lethally irradiated
mice, whereas the majority N-cadherinint Flk2LSK populationCell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 375
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are, however, LT-HSCs. If briefly cultured prior to transplanta-
tion, they provided LT, multilineage reconstitution and self-
renewed to generate both FNint and FNlo LSKs. Microarray
data also firmly supported the idea that FNlo and FNint are
two subpopulations of HSCs; only a small number of genes on
the array were strongly differential between them, and both
were clearly separate from the Flk2+ LSK progenitors.
We also discovered FNlo and FNint LT-HSCs differed in
mobilization efficiency and rate of cell-cycle entry. Moreover,
each expressed a unique spectrum of genes that likely reflects
or governs their distinct activities. These functional and molecu-
lar distinctions led us to propose a model of HSCs in which
Flk2LSKs exist in either ‘‘primed’’ or ‘‘reserved’’ states that
can be distinguished as N-cadherinlo or N-cadherinint (Figure 7).
Properties and Proposed Roles of Primed
and Reserved HSCs
Our data suggest N-cadherinlo HSCs (FNlo) are specifically
prepared (primed) for tasks involving reconstitution, mobiliza-
tion, or response to stimuli and may have more flexible interac-
tions with their environment. Conversely, N-cadherinint HSCs
(FNint) are held back (reserved) from mobilization and may be
receptive to stimuli. We propose that the normal homeostatic
role of primed HSCs is active support of ongoing hematopoiesis,
whereas reserved HSCs are adapted for the role of long-term
maintenance.
Compared with FNint, FNlo HSCs express higher levels of
genes involved in locomotor activity (notably Ccr2) and genes
involved in signaling (Igf2r and Csf1r) and so are primed to
respond more readily to migratory cues and other regulatory sig-
nals. High expression of Nov, which facilitates reconstitution
ability in human HSCs (Gupta et al., 2007), further supports the
argument that primed HSCs may have particular relevance in
HSC transplantation. In contrast, low mRNA expression of
Ccr2, Igf2r, and Csf1r implies that FNint cells have dampened
responsiveness to key growth factors and cytokines. Having
a population that is insulated from migratory or other stimuli
may help prevent depletion of the HSC pool.
Both homing and migration require dynamic changes in the in-
teraction of cells with their environment such as detachment
from microenvironment and transendothelial migration. One
suggestive difference between FNlo and FNint HSCs was
that FNlo cells had lower mRNA levels of Timp2, a negative reg-
ulator of matrix metalloproteinases MMPs, and expressed more
proteinase 3, an activator of MMPs (Pezzato et al., 2003) impli-
cated in facilitating migration of hematopoietic stem/progenitor
cells (Janowska-Wieczorek et al., 2000). We speculate FNlo
HSCs may possess higher MMP activity than FNint and thus
more readily remodel matrix. Conversely, reserved HSCs have
higher N-cadherin protein, higher Itga2b and Timp2 mRNA,
and lower proteinase 3 mRNA, suggesting a more stable rela-
tionship with their environment or niche.
Downregulation of N-cadherin itself may be required for HSC
migration, which may help explain both our transplant results
and our observation that mobilized HSCs are predominantly N-
cadherinlo. A similar concept has been reported in neural crest
cells. N-cadherin expression was found to be higher either prior
to or after migration when cells were anchored or were forming
clusters but was downregulated when cells were actively migrat-
ing (Bronner-Fraser et al., 1992; Kasemeier-Kulesa et al., 2006).
PCA indicated FNint HSCs are less metabolically active than
FNlo and differ in cell-cycle regulation. Indeed, the cell-cycle
entry rate of FNint HSCs (3.2% per day) is only around half
that of FNlo HSCs (6.7% per day) or SLAM code HSCs (6%
per day) (Kiel et al., 2007a). Thus, reserved N-cadherinint HSCs
constitute a substantial pool of relatively inactive and slow-
cycling LT-HSCs. Low metabolic activity and rate of proliferation
could help maintain the integrity of the reserved HSC genome.
Explaining the Performance of HSC Populations
in Reconstitution Assays
The difference in engraftment efficiency of fresh and cultured N-
cadherinint HSCs suggests these cells can be released from their
reserved state but also illustrates an important consideration
regarding reconstitution assays. These vital assays unfortunately
impose a highly artificial challenge, which might better test
a stress response rather than normal, homeostatic activity. We
suggest that for fresh FNint the very properties that fit them
for their reserved role (outlined above) hamper their performance
in reconstitution assays.
The modest reconstitution achieved by CD150+ Flk2LSKs
contrasts with the robust performance of SLAM code
(CD150+CD41CD48) HSCs (Kiel et al., 2005). CD150+
Flk2LSKs contain reserved and primed cells in the same pro-
portions as Flk2LSKs generally. Their reconstitution activity
Figure 7. Model of Reserved and Primed
HSCs
Properties and molecular signatures of reserved
and primed states of HSCs. Reserved HSCs
are adapted for long-term maintenance. Primed
HSCs play a more active role in supporting hema-
topoiesis. Lost primed HSCs may be replaced
from the larger reserved pool (bold forward arrow).
Transition from primed to reserved may also occur
(light reverse arrow).376 Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc.
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makeup. We found that using CD48 and CD41 as negative
markers removed not only progenitor cells but also a large por-
tion of N-cadherinint HSCs, which express higher mRNA levels
of Itga2b (CD41). Thus, in the SLAM code, the negative markers
effectively select primed HSCs, explaining both their robust re-
constitution and the reported difficulty of detecting N-cadherin
(Kiel et al., 2005, 2007b).
Transitions between Reserved and Primed HSCs
Comparing profiles of the differentially expressed genes we
identified with their known expression in stem and progenitor
cells (Akashi et al., 2003; Forsberg et al., 2005; Terskikh et al.,
2003; Tydell et al., 2007) suggests that the primed HSC state
may represent an intermediate step in a progression from re-
served HSCs to the more active ST-HSC and progenitor portions
of the lineage. Our culture data likewise suggest such a hierarchi-
cal relationship is possible: in culture, FNint cells generate or be-
come FNlo, whereas FNlo cultures produce a significant frac-
tion of non-LSKs.
The greater activity/mobility of primed HSCs places them at
risk for depletion, when lost primed HSCs may be replaced by
cells from the reserved pool. Equally, under some situations,
primed HSCs may revert to a reserved state (Figure 7). For exam-
ple, upon transplantation or after homing to BM, some primed
cells may occupy vacant niches that impose a reserved state.
We found that transplant of cultured reserved cells can generate
a normal pattern of both primed and reserved HSCs in recipient
mice. We also observed dynamic changes in N-cadherin expres-
sion following 5FU treatment with primed HSCs ultimately mobi-
lized to PB and spleen. A recent report suggests that reactive ox-
ygen species (ROS) generated by 5FU suppresses N-cadherin
expression in HSCs, causing them to detach from the osteoblas-
tic niche. Thus, ROS may trigger a shift in HSC state (Hosokawa
et al., 2007).
Osteoblastic and Vascular Niches May Differentially
Regulate HSC States
Finding that HSCs can be divided into primed and reserved
pools raises the question of whether these pools reside in phys-
ically separate locations. Previous studies suggest that N-cad-
herin may form an adherent junction between HSCs and the os-
teoblastic niche maintaining HSCs as quiescent (Arai et al., 2004;
Zhang et al., 2003). We therefore suggest that reserved (N-cad-
herinint) HSCs favor the osteoblastic niche. SLAM code HSCs are
known to occupy a vascular niche (Kiel et al., 2005). The obser-
vations that (1) SLAM code cells are mainly N-cadherinlo HSCs
(Figure 2E), (2) homing and mobilized HSCs are enriched with
N-cadherinlo and Slamf1+ cells (Figures 6D, 6F, and 6G), and
(3) N-cadherinlo HSCs and SLAM code HSCs have similar cell-
cycle entry rates (Kiel et al., 2007a) (Figure 4C) suggest that
primed HSCs may tend to occupy a vascular niche. A recent re-
port that HSCs residing in the osteoblastic niche have higher N-
cadherin levels than those in the vascular niche supports this
concept (Jang and Sharkis, 2007). However, further studies are
needed to rigorously establish any relationship between re-
served and primed cells and osteoblastic or vascular niches.
Disrupting one niche type highlights the role of others. If the
osteoblastic niche contains mostly reserved cells, loss or mod-ulation of this niche might have little immediate impact on tis-
sue regeneration. The level of disruption/reduction of niches
may determine phenotype. Biglycan deficiency, which leads
to a reduction in osteoblast number and trabecular bone, is
reported not to alter HSC number (Kiel et al., 2007b), yet
numerous other studies have demonstrated the importance of
osteoblasts as well as osteoclasts, which function in bone re-
modeling, in controlling the number and long-term maintenance
of HSCs (reviewed in Scadden, 2006; Yin and Li, 2006; Kollet
et al., 2006; Walkley et al., 2007a). RARg-deficient and Rb
mutant mice with severe reduction in trabecular bone or oste-
oblasts result in HSC mobilization from BM to spleen, short-
term expansion of HSCs and development of myeloid prolifer-
ative disorder (Walkley et al., 2007a, 2007b). Such changes,
consistent with the proposed functions of the vascular niche
in supporting proliferation and myeloid differentiation (Kopp
et al., 2005), may also be seen as an enforced primed pheno-
type. Irrespective of where they are ultimately located, our
demonstration that HSCs are in distinct reserved and primed




All mice used in this study were housed in the animal facility at Stowers Insti-
tute for Medical Research (SIMR) and handled according to Institute and Na-
tional Institutes of Health (NIH) guidelines. All procedures were approved by
the Institutional Animal Care and Use Committee of SIMR.
Antibody Generation
The anti-N-cadherin mAb was generated from MNCD2 hybridoma cells (ob-
tained from the Hybridoma Bank) injected into nude mice. Ascites fluid was
harvested from which antibodies were purified. These were conjugated with
biotin or phycoerythrin (by Rockland Immunochemicals, Gilbertsville, PA) or
were left unconjugated.
Flow Cytometry Analysis of Hematopoietic Cells
Hematopoietic cells were harvested from spleen, PB, and BM in the femurs
and tibias. Red blood cells were lysed using a 0.30M ammonium chloride so-
lution. For cell surface phenotyping, a lineage cocktail (Lin) was used com-
posed of mAbs recognizing the following markers: CD3, CD4, CD8, CD11b
(Mac1), CD45R (B220), Gr1, IgM, and Ter119 (eBioscience, San Diego, CA).
Monoclonal antibodies against Sca1, cKit, Flk2, CD41, CD48 (eBioscience),
CD150 (BioLegend, San Diego, CA), and N-cadherin (see above) were also
used. For isolation of HSCs, Dynal sheep-anti-Rat magnetic beads (Invitrogen,
Carlsbad, CA) were used with the Lin cocktail to remove the majority of Lin+
cells. The remaining Lin-enriched cells were incubated with appropriate anti-
bodies for further purification using flow cytometry. Cell sorting and analysis
were performed using the MoFlo (Dako, Ft. Collins, CO) and/or the CyAn
ADP (Dako, Ft. Collins, CO).
Competitive Reconstitution Assay
Ten, twenty-five, or one hundred LSK cells from B6 (CD45.2) mouse BM, sub-
divided by expression of combinations of Flk2, N-cadherin, and/or CD150,
were transplanted with 23 105 Ptprc (CD45.1) BM cells into lethally irradiated
Ptprc mice via tail vein injection. Posttransplantation PB samples were taken
from recipient mice and analyzed at 1, 2, 3, 4, or 6 months. The cells were in-
cubated with mAbs against CD45.1, CD45.2, CD11b, Gr1, CD3, and CD45R
(eBioscience). Successful engraftment was defined as the presence of a dis-
tinct CD45.2+CD45.1 population above a background set by parallel analysis
of animals transplanted with only rescue BM.Cell Stem Cell 2, 367–379, April 2008 ª2008 Elsevier Inc. 377
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Methods for RNA extraction, amplification, and microarray analysis were
previously described (Akashi et al., 2003). The result of hybridization of the
derived cRNA to MouseGenome430_2 arrays was scanned with a GeneChip
Scanner 3000 7G using GeneChip Fluidics Station 450 and GeneChip Operat-
ing Software (GCOS 1.4).
5-Fluorouracil Treatment
Mice were injected once via tail vein with 5FU at 150–300 mg/g body weight.
BM and/or spleen tissue was harvested either 1, 3, 5, 7, 10, or 14 days post
5FU treatment.
Quantitative Real-Time RT-PCR
Twelve hundred (1200) N-cadherin+, LinN-cadherin, LinN-cadherinlo,
LinN-cadherinint, Flk2LSK, N-cadloFlk2LSK, and N-cadintFlk2LSK BM
cells were directly sorted into 800 ml Trizol (Ambion, Austin TX). RNA was
extracted and treated for 20 min at 37C with 2 ml RNase-free DNase-1 (2 U/ml;
Ambion) in the presence of 2 ml RNase inhibitor (10 U/ml; Invitrogen). For each
real-time RT-PCR reaction, RNA from each type of sorted cell was divided to
three reactions equivalent to 400 cells.
N-cadherin primers (F2074, 50AGCGCAGTCTTACCGAAGG, and R2075,
50TCGCTGCTTTCATACTGAACTTT) were designed to generate 101 bp ampli-
con spanning the exon2/3 boundary. Real-time RT-PCR reactions were
performed using an iCycler (Bio-Rad iQ5) according to the manufacturer’s
instructions. Amplification of hypoxanthine phosphoribosyl transferase
(HPRT) was used to normalize for sample RNA content. Specificity of products
was confirmed by melting curve analysis, assessing band size in 2% agarose
gels, and DNA sequencing.
Multiplex Gene Analysis in Single-Cell Using RT-PCR
Multiplex single-cell RT-PCR analysis was performed as described previously
(Akashi et al., 2003) with primers specific for Bmi-1, N-cadherin (F2100,
50TGCAAGACTGGATTTCCTGA, and R2101, 50CTCTGCAGTGAGAGGG
AAGC), Slamf1 (CD150), and HPRT. First-round PCR was performed in the
same plate as the RT by adding premixed PCR buffer containing all gene-spe-
cific forward and reverse primers. Second-round PCR with fully nested primers
(F2074 and R2075 for N-cadherin) was performed separately for each gene on
4% aliquots of first-round product.
ACCESSION NUMBERS
The microarray data are available at ArrayExpress (http://www.ebi.ac.uk/
arrayexpress/) under accession number E-TABM-404.
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